Introduction
Melanoma is a malignant tumor that arises from melanocytes, the pigment-producing cells found mainly in the skin but also in the eyes and other tissues. It is typically identified through clinical examination of a suspicious lesion, followed by tissue sampling and microscopic analysis. Because melanoma can grow quickly, invade deeper skin layers, and spread to lymph nodes or internal organs, an accurate diagnosis is essential. Early confirmation allows clinicians to determine the stage of disease and choose the most appropriate treatment before the cancer advances.
Diagnosis is not based on appearance alone. Many benign skin lesions can resemble melanoma, and some melanomas do not look typical. For that reason, medical professionals combine visual assessment, patient history, dermoscopic evaluation, biopsy, and sometimes imaging studies to confirm whether a lesion is cancerous and whether it has spread.
Recognizing Possible Signs of the Condition
Melanoma is often first suspected because a skin spot changes over time or looks different from surrounding moles. One of the best-known warning patterns is the ABCDE approach: asymmetry, irregular border, uneven color, diameter that is larger than expected or increasing, and evolution or change. The last feature, evolution, is especially important because many melanomas are recognized not by a single static appearance but by documented change.
Common clinical signs include a new pigmented lesion in adulthood, a mole that becomes raised or develops nodular thickness, or a patch with multiple shades of brown, black, blue, red, gray, or white. Some melanomas are amelanotic, meaning they contain little pigment and may appear pink, red, or flesh-colored rather than dark. These can be more difficult to identify because they do not show the classic pigment changes associated with melanoma.
Other suspicious findings include itching, tenderness, bleeding, crusting, or ulceration, especially when these changes occur without a clear cause. A lesion on the palms, soles, or under the nails may also raise concern, since acral melanoma and subungual melanoma can appear as dark streaks, irregular patches, or a widening pigmented band in the nail.
Biologically, these visible changes reflect uncontrolled growth of malignant melanocytes and their tendency to invade surrounding skin structures. As the tumor expands, it may disrupt normal pigment distribution, damage the epidermis, and trigger inflammation or ulceration. These effects are why melanoma may change in size, shape, color, and surface texture over time.
Medical History and Physical Examination
Diagnosis begins with a detailed medical history. Clinicians ask when the lesion first appeared, whether it has changed, and whether the patient has noticed bleeding, pain, itching, or rapid growth. They also ask about sun exposure, history of blistering sunburns, tanning bed use, many childhood sunburns, and prior skin cancers. A personal or family history of melanoma is important because inherited risk can increase suspicion, especially in patients with multiple atypical moles or a strong family pattern of disease.
During the physical examination, the clinician inspects the suspicious lesion and often the entire skin surface. This includes looking for other atypical moles, comparing similar lesions, and checking sun-exposed areas as well as less obvious locations such as the scalp, between the toes, the soles, and the nail beds. The examiner may use a dermatoscope, a handheld magnifying device with polarized light that reveals structures not visible to the naked eye. Dermoscopy can help distinguish benign pigment patterns from the irregular networks, atypical dots, streaks, and blue-white areas more suggestive of melanoma.
Healthcare professionals also examine regional lymph nodes, such as those in the neck, armpits, or groin, depending on the location of the lesion. Enlarged or firm nodes may suggest spread, although normal nodes do not exclude metastatic disease. In some cases, total-body photography or digital mole mapping is used for patients with many moles, allowing doctors to detect subtle change over time.
Diagnostic Tests Used for Melanoma
The definitive test for melanoma is a skin biopsy. A biopsy removes all or part of the suspicious lesion so it can be examined under a microscope by a pathologist. The type of biopsy depends on the size and location of the lesion. An excisional biopsy, which removes the entire lesion with a small margin of normal skin, is often preferred when feasible because it provides the most complete information. If excision is not practical, a partial or punch biopsy may be used, though this can sometimes miss the most invasive area if the sample is not representative.
The tissue examination is central to diagnosis. Under microscopy, pathologists assess whether melanocytes are atypical, whether they are spreading along the epidermis, whether there is invasion into the dermis, and how deeply the tumor extends. They also look for features such as mitotic activity, ulceration, and regression. These findings help determine whether the lesion is melanoma and how aggressive it may be.
Several measurements from pathology are especially important. Breslow thickness measures the depth of invasion in millimeters from the top of the skin to the deepest melanoma cell. This is one of the strongest predictors of prognosis. The presence or absence of ulceration, which means a loss of the overlying skin layer, also affects staging and risk assessment. In some cases, the pathologist may report the mitotic rate, which reflects how rapidly the tumor cells are dividing.
Additional laboratory or molecular tests may be performed on the biopsy specimen. Immunohistochemistry uses antibodies that highlight melanocyte-related markers such as S100, SOX10, Melan-A, and HMB-45, helping confirm that the cells are of melanocytic origin. If the diagnosis is uncertain, these stains can distinguish melanoma from other cancers or benign growths. In selected cases, molecular testing may identify mutations such as BRAF, NRAS, or KIT. These tests do not diagnose melanoma by themselves, but they can support classification and guide treatment planning once the diagnosis is established.
Imaging tests are not usually required to diagnose a localized skin melanoma, but they are important when spread is suspected or when staging information is needed. Ultrasound may be used to evaluate nearby lymph nodes. Computed tomography, magnetic resonance imaging, or positron emission tomography combined with CT may be ordered to look for metastases in the lungs, liver, brain, bones, or other organs. Brain MRI is often used when neurologic symptoms or advanced disease raise concern for intracranial spread. These imaging studies measure structural changes or metabolic activity that may indicate tumor deposits beyond the original skin lesion.
A functional test may be performed when melanoma has spread to organs that affect body systems. For example, if there is concern for liver involvement, blood tests may show abnormal liver function values. If the disease is more advanced, clinicians may also check lactate dehydrogenase, or LDH, which can rise with a large tumor burden. These tests do not confirm melanoma on their own, but they help assess the extent of disease and overall physiologic impact.
If a nearby lymph node is suspicious, doctors may perform a sentinel lymph node biopsy after the primary tumor has been diagnosed. This procedure identifies the first lymph node or nodes likely to receive drainage from the tumor area. The nodes are removed and examined microscopically for hidden metastasis. A positive sentinel node indicates that melanoma cells have begun to spread through the lymphatic system, which changes staging and treatment decisions.
Interpreting Diagnostic Results
Doctors interpret melanoma results by combining clinical appearance, microscopic findings, and staging information. A biopsy showing malignant melanocytes with invasion beyond the epidermis confirms melanoma. The pathologist then provides key details such as subtype, Breslow thickness, ulceration, mitotic activity, and margin status. If the lesion was completely removed in the biopsy and the margins are clear, the report may suggest no tumor remains in the sampled tissue. If tumor extends to the edge of the specimen, additional excision is often needed.
Staging is based on how deep the tumor has grown and whether it has spread to lymph nodes or distant sites. A thin, non-ulcerated melanoma confined to the skin may be considered early-stage, while thicker tumors, ulcerated tumors, positive sentinel nodes, or distant metastases indicate more advanced disease. Imaging results, lymph node biopsy findings, and blood work are interpreted alongside pathology rather than in isolation.
When results are ambiguous, specialists may review the slide again or seek a second pathology opinion. This is especially important in borderline lesions such as severely atypical nevi or spitzoid tumors, which can resemble melanoma. In such situations, diagnostic confidence depends on integrating morphology, immunostains, clinical context, and sometimes genomic data.
Conditions That May Need to Be Distinguished
Several benign or non-melanoma conditions can resemble melanoma. Common examples include benign melanocytic nevi, dysplastic nevi, seborrheic keratoses, lentigines, and dermatofibromas. These lesions may be pigmented or irregular in shape, but they generally lack the invasive growth pattern seen in melanoma. Dermoscopy and biopsy are used to distinguish them from cancer.
Inflamed or traumatized moles can also look worrisome if they become red, crusted, or irritated. Pigmented basal cell carcinoma may resemble melanoma in some cases, particularly when it contains dark pigment. Blue nevus, pigmented actinic keratosis, and post-inflammatory hyperpigmentation can create additional diagnostic confusion.
On the nails, subungual melanoma must be differentiated from trauma, fungal infection, melanonychia due to benign causes, and pigment from medications or ethnic variation. On palms and soles, acral melanoma can be mistaken for bruising, wart-like lesions, or chronic frictional pigmentation. Because melanoma can mimic many benign findings, clinicians rely on change over time, lesion asymmetry, irregular pigmentation, and histologic confirmation rather than appearance alone.
Factors That Influence Diagnosis
Several factors affect how melanoma is diagnosed and how quickly the process proceeds. Lesion location is important because melanomas on the scalp, nail unit, palms, soles, or genital skin can be harder to notice and may require a lower threshold for biopsy. Lesions in older adults are also scrutinized differently because a new pigmented lesion appearing later in life can be more concerning than a stable mole that has been present for years.
Skin type, sun exposure history, and the number of moles a person has can influence clinical suspicion. Patients with fair skin, a history of intense ultraviolet exposure, or multiple atypical nevi may be examined more closely, but melanoma can occur in any skin type. In darker skin, acral and mucosal melanoma are relatively more common, and diagnosis may be delayed if lesions are mistaken for benign pigmentation.
Related medical conditions also matter. Immunosuppression, whether from organ transplantation, medications, or disease, can increase melanoma risk and may prompt more aggressive evaluation. Genetic syndromes and family history can lead to earlier surveillance and more frequent skin examinations. If the tumor appears advanced, symptoms such as weight loss, headaches, neurological deficits, or enlarged lymph nodes may trigger imaging sooner.
The extent of disease at presentation shapes the diagnostic pathway as well. A small, clearly suspicious lesion may be treated with excisional biopsy and pathology alone, while a thicker tumor or one with symptoms suggesting spread often requires staging scans, node evaluation, and laboratory testing. Thus, diagnosis is not a single test but a layered process tailored to the clinical situation.
Conclusion
Melanoma is diagnosed through a combination of clinical assessment, careful skin examination, tissue biopsy, and, when needed, imaging and laboratory studies. Doctors look for changing or atypical lesions, assess risk factors and lesion behavior, and then confirm the diagnosis by examining tissue under the microscope. Pathology determines whether the lesion is melanoma and measures features that define how deeply it has invaded and whether it has begun to spread.
Because melanoma can resemble many harmless skin conditions and may present in subtle or unusual forms, accurate diagnosis depends on both clinical judgment and histologic confirmation. The process is designed not only to identify the cancer but also to stage it accurately, which is essential for predicting outcome and guiding treatment.